hjc888黄金城

As a pharmaceutical company originating hundreds of years ago, Jiuzhitang set its sight on the future and made the strategic arrangement of developing China’s stem cell sector: reconfiguring the landscape of regenerative medicine by giving full play to company’s strength as a player in the Traditional Chinese Medicine industry and leveraging leading global stem cell technologies. This endeavor aims at pioneering a path of innovation suitable for China’s time-honored pharmaceutical businesses by integrating traditional Chinese medical science with the cutting-edge biotechnology in development and production of stem cell products.

Initiated by Jiuzhitang Co., Ltd., Yonghe Qihang Fund founded Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. (“Jiuzhitang Maker”) in March 2018 with an investment amounting to 200 million yuan. Jiuzhitang Maker is a biotechnology company focused on the manufacture, R&D and sales of stem cell-based drugs and regenerative care products.

Jiuzhitang Maker built a large-scale allogenic stem cells R&D and manufacturing facility that meets Chinese, US and EU cGMP standards in ZGC Biomedicine Industry Park, Daxing District, the first of its kind in Beijing. The facility is capable of manufacturing clinical grade stem cell products compliant with Chinese and US drug application requirements.